SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-20-012430
Filing Date
2020-08-11
Accepted
2020-08-11 16:04:58
Documents
7
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K auph-0630206xk.htm 6-K 17954
2 EXHIBIT 99.1 exhibit991-20200630interim.htm EX-99.1 694439
3 EXHIBIT 99.2 exhibit992-20200630mda.htm EX-99.2 398128
4 EXHIBIT 99.3 exhibit993-20200630certifi.htm EX-99.3 15734
5 EXHIBIT 99.4 exhibit994-20200630certifi.htm EX-99.4 15727
6 a2002aurinialogoa01.jpg GRAPHIC 121945
7 imagemktgchart.jpg GRAPHIC 9102
  Complete submission text file 0001628280-20-012430.txt   1323602
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 201092421
SIC: 2834 Pharmaceutical Preparations